Diety bezzbożowe w żywieniu psów

Piśmiennictwo

1. Bellumori T.P., Famula T.R., Bannasch D.L., Belanger J.M., Oberbauer A.M.: Prevalence of inherited disorders among mixed-breed and purebred dogs: 27,254 cases (1995-2010). „J Am Vet Med Assoc”, 2013, 242, 1549-1555.
2. Cadogan D.J., Choct M.: Pattern of non-starch polysaccharide digestion along the gut of the pig: Contribution to available energy. „Anim Nutr”, 2015, 1, 160-165.
3. Dalmeijer G.W., Olthof M.R., Verhoef P., Bots M.L., van der Schouw Y.T.: Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. „Eur J Clin Nutr”, 2008, 62, 386-394.
4. Dow S.W., Fettman M.J., Smith K.R., Ching S.V., Hamar D.W., Rogers Q.R.: Taurine depletion and cardiovascular disease in adult cats fed a potassium-depleted acidified diet. „Am J Vet Res”, 1992, 53, 402-405.
5. Dukes-McEwan J., Borgarelli M., Tidholm A., Vollmar A.C., Häggström J.: Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy. „J Vet Cardiol”, 2003, 5, 7-19.
6. Fennema D., Phillips I.R., Shephard E.A.: Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease. „Drug Metab Dispos”, 2016, 44, 1839-1850.
7. Freeman L.M., Rush J.E., Milbury P.E., Blumberg J.B.: Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. „J Vet Intern Med”, 2005, 19, 537-541.
8. Freeman L.M., Stern J.A., Fries R., Adin D.B., Rush J.E.: Diet-associated dilated cardiomyopathy in dogs: what do we know? „J Am Vet Med Assoc”, 2018, 253, 1390-1394.
9. Gibson R.S.: The role of diet- and host-related factors in nutrient bioavailability and thus in nutrient-based dietary requirement estimates. „Food Nutr Bull”, 2007, 28, 77-100.
10. Huxtable R.J.: Physiological actions of taurine. „Physiol Rev”, 1992, 72, 101-163.
11. Ko K.S., Fascetti A.J.: Dietary beet pulp decreases taurine status in dogs fed low protein diet. „J Anim Sci Technol”, 2016, 58, 29.
12. Loscalzo J., Handy D.E.: Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). „Pulm Circ”, 2014, 4, 169-174.
13. Mansilla W.D., Marinangeli C.P.F., Ekenstedt K.J., Larsen J.A., Aldrich G., Columbus D.A., Weber L., Abood S.K., Shoveller A.K.: Special topic: The association between pulse ingredients and canine dilated cardiomyopathy: addressing the knowledge gaps before establishing causation. „J Anim Sci”, 2019, 97, 983-997.
14. McCauley S.R., Clark S.D., Quest B.W., Streeter R.M., Oxford E.M.: Review of canine dilated cardiomyopathy in the wake of diet-associated concerns. „Journal of Animal Science”, 2020, 98, 155.
15. Randrianarisoa E., Lehn-Stefan A., Wang X., Hoene M., Peter A., Heinzmann S.S., Zhao X., Königsrainer I., Königsrainer A., Balletshofer B., Machann J., Schick F., Fritsche A., Häring H.U., Xu G., Lehmann R., Stefan N.: Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans. „Sci Rep”, 2016, 6, 26745.
16. Sanderson S.L., Gross K.L., Ogburn P.N., Calvert C., Jacobs G., Lowry S.R., Bird K.A., Koehler L.A., Swanson L.L.: Effects of dietary fat and L-carnitine on plasma and whole blood taurine concentrations and cardiac function in healthy dogs fed protein-restricted diets. „Am J Vet Res”, 2001, 62, 1616-1623.
17. Schaffer S., Kim H.W.: Effects and Mechanisms of Taurine as a Therapeutic Agent. „Biomol Ther”, 2018, 26, 225-241.
18. Schwab U., Törrönen A., Toppinen L., Alfthan G., Saarinen M., Aro A., Uusitupa M.: Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. „Am J Clin Nutr”, 2002, 76, 961-967.

dr inż. Jacek Wilczak
Zakład Biochemii i Dietetyki
Katedra Nauk Fizjologicznych
Instytut Medycyny Weterynaryjnej
Szkoła Główna Gospodarstwa Wiejskiego w Warszawie
ul. Nowoursynowska 159 02-776 Warszawa